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Objective: Since IVF program was first established, various types of media and culture systems have been developed either in-house or com-
mercially. The aim of this study was to compare the efficacy of in-house Maria Research Center (MRC) media to that of commercially available 
Sydney IVF media in human day 3 embryo transfer cycles. 
Methods: Three hundred sixty nine couples were included in this prospective, randomized, and comparative study. All couples undergoing IVF 
treatment at the Maria Fertility Hospital were randomly assigned to either Sydney IVF (n=178) or MRC (n=191) media. 
Results: No difference was observed between the MRC media and Sydney IVF media groups with respect to fertilization rate (74.4% vs. 75.5%). 
The clinical pregnancy and implantation rates of MRC media (47.1% and 20.0%, respectively) were also similar to those of Sydney IVF media 
(44.4% and 19.4%, respectively). However, the proportion of embryos with good quality on day 3 was significantly higher in the MRC media 
group than the Sydney IVF media group (50.2% vs. 43.2%) (p<0.05). 
Conclusion: MRC media were as effective as Sydney IVF media for sustaining embryo development and pregnancy rates. The present study 
implies that MRC media can be a suitable alternative to commercially available media for human IVF-ET program. 
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Introduction
Since IVF program was first established, a large number of media 
and culture systems have been developed. Maria Fertility Hospital 
has used YS medium for controlled ovarian hyperstimulation and 
IVM cycles of human IVF [1-4]. YS medium has been shown to sup-
port the development of both oocytes and zygotes to the blastocyst 
stage in co-culture systems composed of autologous cumulus cells 
and human follicular fluid. This culture system also achieved an ac-
ceptable pregnancy rate in a human IVF-ET program [1,2]. However, 
there are potential disadvantages associated with this system, in-
cluding quality control difficulties and being time-consuming and 
labor intensive [5-7]
To avoid those problems, quality-controlled commercial media have 
been used in many IVF laboratories [7]. Nevertheless, commercial 
media are costly and difficult to compare directly because their exact 
compositions are not clearly indicated [8-10]. Furthermore, clinical 
outcomes of commercially available sequential media have been re-
ported to be in the same range as those obtained using a co-culture 
system [11-14]. 
Accordingly, the use of in-house synthetic sequential media would 
be desirable in a human IVF-ET program to avoid disadvantages as-
sociated with co-culture systems and commercial media and to ob-
tain a high pregnancy rate. Consequently, a synthetic sequential me-
dia known as Maria Research Center (MRC) media were newly devel-
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oped after modifying the YS medium. The present study was con-
ducted to compare the efficacy of MRC media in the human IVF-ET 
program to that of commercially available media.
Methods
1.	Inclusion	criteria
The present study was conducted following approval by the Insti-
tutional Board of the Maria Fertility Hospital. This study included wo-
men younger than 40 years old who visited Maria Fertility Hospital at 
Seoul from November 2009 to September 2010. Ovarian stimulation 
was induced by GnRH agonist long treatment or GnRH antagonist 
short treatment. 
Patients were randomly assigned to one of two media, Sydney IVF 
media as a control group and MRC media as a trial group (Table 1), at 
oocytes retrieval. A series of Sydney IVF media consisting of Sydney 
IVF fertilization medium (COOK, Brisbane, Australia), Sydney IVF clea-
vage medium (COOK) and Sydney IVF blastocyst medium (COOK) was 
used at our discretion as a representative of commercially available 
media. Those patients who showed either fertilization failure in both 
two groups or less than two 2 pronuclear embryos in either of the 
two groups were excluded. 
2.	Preparation	of	MRC	media
A series of MRC media consisting of MRC#D01 for fertilization, MRC 
#D13 for cleavage growth and MRC#D46 for blastocyst growth was 
newly tailored by modifying the YS medium. All MRC media were 
designed to meet the nutritional requirements specific to embryonic 
stages (Table 1) [15-20]. Each medium was prepared using sterile wa-
ter for injection in a class 1,000 clean room and then examined to en-
sure that it met the standard manufacturing specifications, including 
quality control tests using a mouse embryo assay (MEA), pH measure-
ment, osmolarity tests, and endotoxin assays. All MRC media had si-
milar parameters of osmolarity and pH in a 6% CO2 atmosphere at 
37°C (278 to 280 mOsm/kg and 7.30 to 7.45, respectively).
3.	Application	of	MRC	media	to	human	IVF-ET	cycles
Oocytes retrieval was conducted approximately 36-38 hours after 
hCG injection by transvaginal ultrasound guidance. Oocytes of the 
control group were cultured in Sydney IVF fertilization medium, while 
those of the trial group were incubated in MRC#D01 medium. Fertil-
ization was induced by either conventional IVF or ICSI approximately 
4-6 hours after oocytes retrieval and confirmed approximately 17-19 
hours after insemination. Zygotes in the control group were cultured 
in Sydney IVF cleavage medium, whereas those of the trial group were 
cultured in MRC#D13 medium. The culture conditions were 40 µL dro-
plets in a 6% CO2, 5% O2, and 89% N2 incubator at 37°C. Embryo de-
velopment was monitored daily and embryo grades were assessed 
based on the number of blastomeres and the amount of cellular frag-
mentation. On day 3, the embryos were classified into four grades: 
embryos which reached the 6-cell or more stage and had no cyto-
plasmic fragmentation (grade 1); embryos which reached 6-cell or 
more stage but less than 20% cytoplasmic fragmentation (grade 2); 
embryos which developed 6-cell or more stage but had 20-50% cy-
toplasmic fragmentation or embryos which did not reach the 6-cell 
stage but had less than 50% cytoplasmic fragmentation (grade 3); 
and embryos which did not reach 6-cell and had more than 50% cy-
toplasmic fragmentation (grade 4). Grade 1 and grade 2 were regard-
ed as good-quality. The mean and SD of the embryo quality were 
calculated for each media group among individual patients. Those 
embryos with the highest scores from individual patients were trans-
ferred on day 3 using an embryo transfer catheter (COOK). 
Supernumerary embryos in the control group were cultured in Syd-
ney IVF blastocyst medium, while those in the trial group were cul-
tured in MRC#D46 medium. Embryos that reached the expanded 
blastocyst stage were vitrified and cryopreserved in liquid nitrogen 
[21]. 
Clinical pregnancy was assessed by the presence of a gestational 
sac and fetal heart beat at 5-6 weeks after the embryo transfer. On-
going pregnancy was followed up by the presence of a fetal heart 
Table	1. Alterations of YS medium into sequential Maria Research Cen-
ter (MRC) media for different applications
Media     Applications                          Alterations
MRC#D01  Fertilization 102.7 mM  sodium chloride
0.58 mM  glucose
0.50 mM  alanyl-glutamine
0.50 mM  glycyl-glutamine
10.50 mM  sodium lactate
5.0 mg/mL  human serum albumin
1.0 mg/mL alpha and beta globulins
MRC#D13  Cleavage culture 102.7 mM  sodium chloride
0.58 mM  glucose
0.50 mM  alanyl-glutamine
0.50 mM  glycyl-glutamine
10.50 mM  sodium lactate
0.10 mg/mL  hyaluronic acid
5.0 mg/mL  human serum albumin
1.0 mg/mL  alpha and beta globulins
MRC#D46 B lastocyst  
production
106.0 mM  sodium chloride
3.15 mM  glucose
0.50 mM alanyl-glutamine
0.50 mM glycyl-glutamine
5.87 mM sodium lactate
0.10 mg/mL hyaluronic acid
5.0 mg/mL human serum albumin
1.0 mg/mL alpha and beta globulins  http://dx.doi.org/10.5653/cerm.2011.38.4.186
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beat 10 weeks after embryo transfer. 
4.	Statistical	analyses
Statistical analyses were conducted using the χ
2 test to compare 
the embryo qualities, clinical and ongoing pregnancy rates, and im-
plantation rates of the two groups. A t-test was used to compare the 
number of retrieved oocytes, normal zygotes, and transferred em-
bryos. Data were analyzed with SPSS (SPSS Inc., Chicago, IL, USA) and 
a p-value less than 0.05 was considered statistically significant.
Results
A total of 369 human IVF-ET cycles were assessed in the present 
study. Oocytes and zygotes of 178 cycles were sequentially cultured 
in Sydney IVF media as a control group, while those of 191 cycles were 
sequentially incubated in MRC media as a trial group. Several charac-
teristics of patients are presented in Table 2. Patient age, infertility in-
dications, and previous IVF attempts did not different between groups. 
In addition, there was no difference in the proportion of GnRH ago-
nist administrations (71.3% vs. 66.0%) and ICSI trials (36.5% vs. 35.6%) 
observed between groups (Table 2). 
The number of oocytes collected from the control group was simi-
lar to that collected from the trial group (10.8±5.8 vs. 10.6±6.0) (Ta-
ble 3). In addition, there was no difference in the number of meta-
phase II stage oocytes between the control and trial groups at retri-
eval (8.5±4.7 vs. 8.4±4.8). The fertilization rate of the trial group was 
also similar to that of the control group (74.4% vs. 75.5%). However, 
the proportion of embryos with good quality on day 3 was significant-
ly higher in the trial group than the control group (50.2% vs. 43.2%) 
Table	2. Comparison of characteristics obtained using sequential MRC 
media and Sydney IVF media
Available sequential media
p-value
Sydney IVF  MRC 
Cycles  178 191 -
GnRH agonist long (%) 71.3 66.0 NS
GnRH antagonist short (%) 28.7 34.0 NS
Age (yr) 33.4±3.2 33.8±2.8 NS
Previous attempts  1.7±1.1 1.6±0.9 NS
Indications - - -
Male factor  12.9 15.7 NS
Tubal factor  22.5 26.2 NS
Ovulation  6.2 5.2 NS
Endometriosis  5.1 5.8 NS
Unexplained  44.9 39.3 NS
Multiple factors  3.9 5.8 NS
Other  4.5 2.1 NS
Cycles with ICSI  65 (36.5) 68 (35.6) NS
Values are presented as number (%) or mean±SD.
MRC, Maria Research Center; NS, not significant.
Table	3. Comparison of clinical outcome of sequential MRC media to Sydney IVF media
Available sequential media
p-value
Sydney IVF  MRC 
Cycles  178 191 -
Oocytes collected  1,931 (10.8±5.8) 2,025 (10.6±6.0) NS
Mature oocytes at retrieval  1,520 (8.5±4.7) 1,608 (8.4±4.8) NS
Normal zygotes  1,147 (75.5) 1,196 (74.4) NS
Good quality embryos on day 3  495 (43.2) 600 (50.2) <0.05
Embryos transferred  475 (2.7±0.5) 509 (2.7±0.5) NS
Good quality embryos at ET (%) 70.1 78.8 <0.05
Cycles with surplus embryos (%) 159 142 -
Cycles with 1-2 (%) 35.2 28.9 NS
Cycles with 3-6 (%) 42.8 46.5 NS
Cycles with 7-9 (%) 15.7 15.5 NS
Cycles with ≥10 (%) 6.3 9.2 NS
Cycles with embryo preservation  54 (34.0) 52 (36.6) NS
Clinical pregnancies  79 (44.4) 90 (47.1) NS
Embryos implanted  92 (19.4) 102 (20.0) NS
Ongoing pregnancies  66 (37.1) 75 (39.3) NS
Single (%) 63.6 66.7 NS
Twin (%) 33.3 30.7 NS
Triple (%) 3.0 2.7 NS
Values are presented as number (%) or mean±SD.
MRC, Maria Research Center; NS, not significant.www.eCERM.org
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(p<0.05). The proportion of transferred embryos with good quality 
was also higher in the trial group than in the control group (78.8% vs. 
70.1%) (p<0.05). The qualities of day 3 embryos were not signifi-
cantly influenced by inter-batch variations in either group (Figure 1). 
The number of cycles with surplus embryos was 159 cycles for the 
control group and 142 cycles for the trial group (Table 3). When the 
embryos that reached the expanded blastocyst stage were vitrified 
and cryopreserved, differences in the proportion of cycles with em-
bryo cryopreservation were not observed between the control and 
trial groups (34.0% vs. 36.6%) (Table 3). 
The clinical and ongoing pregnancy rates of the trial group (47.1% 
and 39.3%, respectively) were similar to those of the control group 
(44.4% and 37.1%, respectively) (Table 3). Similarly, the implantation 
rate of the trial group was identical to that of the control group (20.0% 
vs. 19.4%) (Table 3).
Discussion
YS medium containing hFF has been shown to support fertilization 
of human oocytes and development of human zygotes to the blas-
tocyst stage on a cumulus cell monolayer, resulting in an acceptable 
pregnancy rate [1-4]. However, several reports claimed that the use 
of maternal serum and co-culture with feeder cells was associated 
with high rates of fetal loss, potential for sample identification error, 
and possible induction of embryo-toxic factors into the IVF media 
[11,13,14]. Therefore, Maria Fertility Hospital has newly developed 
sequential culture media by modifying the YS medium that were spe-
cialized for fertilization (MRC#D01), cleavage (MRC#D13), and blasto-
cyst growth (MRC#D46) (Table 1). The present comparative and ran-
domized study was conducted to compare the efficacy of the series 
of MRC media to that of commercially available media in a human 
day 3 embryo transfer program.
A number of studies have been conducted to compare the effec-
tiveness of commercially available media types for embryo growth 
and pregnancy rates. Mauri et al. [7] compared P1 medium to IVF-50 
medium, while Zollner et al. [22] compared G1.2/G2.2 media to M1/
M2 media. They concluded that there were no significant differences 
in the pregnancy and implantation rates between the two types of 
media. However, Van Langendonckt et al. [23] reported that the G1.2/ 
G2.2 media group had higher pregnancy and implantation rates than 
the Sydney IVF media group, especially in a group of patients having 
at least five zygotes. Ben-Yosef et al. [24] compared P1 media to Syd-
ney IVF media and found that the P1 Media appeared to be associat-
ed with a higher embryo cleavage rate and improved implantation 
rates. Recently, Sifer et al. [25] reported that GIII series significantly 
improved day 2 and day 3 embryo qualities when compared to ISM 
1/2 media, along with higher rates in clinical pregnancy and implan-
tation. Collectively, these previous reports indicate that each type of 
media has its unique distinct properties over other media types dur-
ing specific stages of the human IVF-ET program and that each type 
of media results in various outcomes depending on the different IVF-
ET program regimes. 
Thus, Maria Fertility Hospital conducted randomized preliminary 
studies to select a control media group among commercially avail-
able P1, G1.5/2.5, and Sydney IVF media (data not shown). The em-
bryo quality and clinical pregnancy rate were higher in the Sydney 
IVF media group than in other media groups, even though previous 
studies revealed that embryos cultured in Sydney IVF media display-
ed lower pregnancy rates than G1.2/2.2 or P1 media [23,24]. As a re-
sult, the series of Sydney IVF media was used as a representative com-
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Figure	1. Day 3 good quality embryo rate among batches of sequential MRC media compared to Sydney IVF media.  http://dx.doi.org/10.5653/cerm.2011.38.4.186
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mercially available media (control group) for comparison with the se-
ries of MRC media (trial group). 
All variables, such as patient ages, infertility indications, previous 
IVF attempts, and ICSI cycle ratio, did not differ between the control 
and trial groups (Table 2). The rates of implantation, clinical pregnan-
cy, and ongoing pregnancy in the trial group were identical to those 
in the control group. The only difference between groups was the 
quality of day 3 embryos. Specifically, the embryos cultured in the 
series of MRC media had a better morphological quality and showed 
a lower fragmentation rate than those cultured in the series of Syd-
ney IVF media (p<0.05), resulting in a higher quality of transferred 
embryos in the series of MRC media than the series of Sydney IVF 
media (78.8% vs. 70.1%) (p<0.05). After transferring a maximum of 
three good quality embryos per cycle, the supernumerary embryos 
were sequentially cultured in each group. The embryonic develop-
ment to the blastocyst stage was equal in both groups and the num-
ber of cycles with blastocyst cryopreservation did not differ signifi-
cantly between the control and trial groups (34.0% vs. 36.6%) (Table 
3). Although embryonic development was superior in the MRC me-
dia group on day 3, pregnancy rates and the number of cryopreser-
vation cycles were nearly the same in both groups. This observation 
was similar to the results of a previous study [23] in which embryos 
cultured in Sydney IVF media had a better morphological aspect, but 
showed a lower implantation rate than those obtained in the series 
of G media (Vitrolife). These results suggest that embryo morphology 
is not a reliable marker for comparing different types of culture me-
dia for pregnancy rates. In this regard, several studies have demon-
strated that traditional criteria for embryo selection on day 3 for ET 
may be limited by the fact that the embryos are still partially depen-
dent on the maternal genome [26,27]. The embryonic genome is ful-
ly activated after the 8-cell stage, implying that the blastocyst forma-
tion on day 5 offers more information regarding the implantation 
potential [26-29]. Consequently, additional randomized studies of 
blastocyst formation or blastocyst transfer outcomes using the series 
of MRC media are necessary. 
Early embryonic development can be differentially controlled by 
varying the nutritional composition of the culture media. However, it 
is difficult to identify what is responsible for better embryo quality 
since precise nutritional compositions of most culture media are not 
publicly known. Based on the technical bulletin of Sydney IVF media, 
there are two major differences between Sydney IVF media and MRC 
media. The first difference is the presence of alpha- and beta-globu-
lin in MRC media. Several studies have reported that the use of syn-
thetic serum substitute containing alpha- and beta-globulin has be-
neficial effects during the culture of human and mouse embryos 
[18,20,30]. The second difference is the use of hyaluronic acid in MRC 
media, which is found at high concentrations in the fluid of the fe-
male reproductive tract [31-33]. However, the rates of clinical preg-
nancy and implantation were similar between both groups, even 
though MRC media had a better morphological aspect than Sydney 
IVF media. Macklon et al. [34] and Van den Bergh et al. [35] insisted 
that when producing and managing a culture system, quality more 
important to successful human embryo culture than the type of me-
dia, indicating the importance of the establishment of a standard 
method for the quality control of media. Maria Fertility Hospital es-
tablished standardized quality control procedures, such as MEA, os-
molarity- and pH-controls, and endotoxin testing, and applied them 
to screen embryo toxicity in chemicals and media. Gardner et al. [36] 
reported that the results of quality control are dependent on the 
strain of mice used because inbred strains and their F1 hybrids are 
less sensitive to their environment than outbred strains of mice. In 
the present study, B6D2 F1 mice for MEA were used because the CF-1 
outbred mice were not commercially available on a regular basis with-
in Korea. However, it is thought that B6D2 F1 mice embryos are suit-
able for MEA because good quality embryos and a high pregnancy 
rate were obtained in human IVF using media screened with these 
embryos. Nevertheless, further studies comparing the effectiveness 
between B6D2 F1 mice and other outbred mice are needed to estab-
lish a critical quality control method. 
Although commercially available media have commonly been used 
in most IVF programs worldwide, there are several advantages to the 
use of in-house synthetic sequential media at IVF laboratories. First, 
the results of quality control should be reliable due to a stringent pro-
tocol setting-up. Second, any direct supplementations or deletions of 
specific components are feasible to obtain good quality embryos and 
high pregnancy rates since those components can be defined. Final-
ly, dependence on commercially available media diminishes so that 
the laboratory can more easily accommodate unexpected situations 
or problems, such as a sudden increase in IVF patients. Despite these 
advantages, inter-batch variations of in-house media have been re-
ported to be a major problem in clinical settings [5-7]. Therefore, data 
obtained in this study were analyzed to determine if inter-batch vari-
ations influenced embryo quality. There were eight batches used 
that had over 10 IVF cycles per batch in each group of the present 
study. The results showed that the quality of day 3 embryos was not 
affected by inter-batch variations in either group (Figure 1), which 
was consistent with the results of a previous study conducted by 
Aoki et al. [37]. However, additional studies should be conducted to 
elucidate the possible effects of inter-batch variation on implanta-
tion and pregnancy rates.
In conclusion, MRC media were developed by alteration in YS me-
dium in accordance with stage-specific requirements based on the 
nutritional components of oviduct and uterine fluids. It would be de-
sirable to avoid the disadvantages of serum and commercial media. www.eCERM.org
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The present randomized study showed that there are no significant 
differences between MRC media and Sydney IVF media regarding 
pregnancy, implantation rates, and the proportion of cycles with cryo-
preservation. Therefore, the results of the present study suggest that 
the series of MRC media can be a suitable alternative to commercially 
available media for human IVF-ET programs.
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